Electrical defibrillation is the only effective therapy for cardiac arrest caused by ventricular fibrillation (VF) [1, 2] or pulseless ventricular tachycardia (VT). Scientific evidence to support early defibrillation is overwhelming [3-5], being delay from collapse to delivery of the first shock the single most important determinant of survival [6, 7]. If defibrillation is delivered promptly, survival rates as high as 75% have been reported [8, 9]. The chance of a favourable outcome decline at a rate of about 10% for each minute cardiac defibrillation is delayed [3, 10]. The guidelines on cardiopulmonary resuscitation of the European Resuscitation Council and American Heart Association (AHA) strongly recommend attempting defibrillation with minimal delay in victims of VF/VT cardiac arrest. As this event occurs most often in the victim’s private home or in public spaces away from healthcare facilities, the need for early defibrillation has led to the development of automatic, portable defibrillators (Automated External Defibrillator - AED). The purpose of this chapter is to review the mechanisms of external defibrillation, the available types of AEDs including the wearable cardioverter-defibrillator, its uses and limitations. Advertisement In Switzerland, 1899, Prevost and Batelli discovered that small electric shocks could induce ventricular fibrillation in dogs and that larger charges would reverse the condition. However it was not until 1956 when alternating current was first used for transthoracic defibrillation to treat ventricular fibrillation in humans [11]. Following this breakthrough, direct current defibrillators were introduced into clinical practice around 1962 [12] when it was demonstrated that electrical countershock or cardioversion across the closed chest could abolish other cardiac arrhythmias in addition to ventricular fibrillation [13]. Later on, Diack et al. [14] described the first clinical experience with an AED. Subsequently, further studies provided solid evidence on the potential role of these devices in the early defibrillation and survival.
Most current AEDs are energy-based but there are two other types of defibrillators less frequently used in clinical practice.
Cardioversion is one of the possible treatments for arrhythmias that imply a re-entrant circuit. By delivering a synchronized electric shock all excitable tissue of the circuit is simultaneously depolarised making the tissue refractory and the circuit no longer able to sustain re-entry. As a result, cardioversion terminates arrhythmias resulting from a single reentrant circuit, such as atrial flutter, atrioventricular nodal reentrant tachycardia or monomorphic ventricular tachycardia. This term is also applied when using an electrical shock to terminate atrial fibrillation although this arrhythmia involves multiple, micro-reentrant circuits. The term cardioversion implies to syncronize the delivery of the shock with the QRS complex of the patient. Defibrillation is used to describe the utilization of an electric shock to terminate ventricular fibrillation (VF). VF is known to be a very persistent arrhythmia, and total elimination of the fibrillatory activity is obtained only with a relatively high energy shock that uniformly depolarizes the entire myocardium. Current European Society of Cardiology and AHA guidelines suggest the following initial energy selection for specific arrhythmias [26-28]:
Cardioversion is most commonly used for the treatment of atrial fibrillation and the development of biphasic defibrillators proved to be very useful. At least 2 randomized trials illustrated the benefit of the biphasic waveform when compared to escalating monophasic shocks [29, 30]. First shock efficacy was greater with a biphasic waveform (68 versus 21 percent), delivered energy was 50 percent less, and the overall cardioversion rate was higher (94 versus 79 percent) [29]. There were fewer total shocks (1.7 versus 2.8), less energy delivered (217 versus 548 joules), and a lower frequency of dermal injury (17 versus 41 percent) [30]. Similar findings were reported for patients with atrial flutter, in whom cardioversion was successful more frequently and at lower energy levels when using biphasic waveforms [31]. Advertisement The term refers to a portable and lightweight computerized device that incorporates rhythm analysis and defibrillation systems and uses voice and/or visual prompts to guide lay rescuers and healthcare providers to safely defibrillate victims of cardiac arrest due to VF or pulseless VT. There are two types of AED: the semi-automatic that indicates the need for defibrillation but requires that the operator deliver the shock by pushing a button and the fully automatic AED which is capable of administering a shock without the need for outside interventions. See Table 1. Basically these devices consist of a battery, a capacitor, electrodes and an electrical circuit designed to analyze the rhythm and send an electric shock if is needed.
Definition, main advantages and disadvantages for the different types of AED available. Appearance of a common AED with pads attached Defibrillation is considered successful when it terminates VF for at least 5 seconds following the shock [32]. DFT is the lowest effective energy needed to restore the cardiac rhythm. Defibrillation basically depends on successful energy selection and TTI. Modern AEDs are energy-based devices that can deliver the electrical shock in a monophasic or biphasic waveform. Although monophasic AEDs are not currently manufactured anymore they are still relatively easy to find in clinical practice. Energy levels vary by the type of device and the optimal energy level for defibrillation has not been determined yet. Studies comparing biphasic shocks to a more traditional approach with 3 monophasic escalating shocks [33,34] have shown that defibrillation with relatively low energy (≤ 200 J biphasic) is safe and has equivalent or higher efficacy for termination of VF than monophasic waveform shocks of equivalent or higher energy [35-41]. However optimal energy for this first shock has not been determined so that for biphasic defibrillators, one should use the manufacturer’s recommended energy dose (120 to 200 J). If the manufacturer’s recommended dose is not known, defibrillation at maximal dose may be considered. Commercially available biphasic AEDs provide either fixed or escalating energy levels. Human studies have not demonstrated evidence of harm from any biphasic waveform defibrillation energy up to 360 J [40, 41]. Based on available evidence, the second and subsequent shocks should be at an energy level equivalent or higher than the first one if possible. In the absence of biphasic defibrillators, monophasic ones are acceptable. A recommendation for higher initial energy when using a monophasic waveform was weighed by expert consensus taking in consideration the potential negative effects of a high-energy first shock versus the negative effects of prolonged VF [42]. The consensus recommends that rescuers using monophasic AED should give an initial shock of 360 J. This single dose for monophasic shocks is designed to simplify instructions to rescuers but is not a mandate to recall monophasic AEDs for reprogramming. If the monophasic AED being used is programmed to deliver a different first or subsequent dose, that dose is acceptable. It refers to the dissipation of energy in the lungs, thoracic cage and the other anatomic structures of the chest. In an animal study, only 4% of the energy supplied reached the heart [43]. The average adult human TTI is ≈70-80 Ω and is determined by multiple factors including energy level, electrode size, interelectrode distance, interface skin-electrode, electrode pressure, phase of ventilation, myocardial tissue and blood conductive properties [44]. When TTI is too high, a low-energy shock will not generate sufficient current to achieve defibrillation [44, 45]. To reduce TTI, the defibrillator operator should use conductive materials. This is accomplished with the use of gel pads or electrode paste [46] with paddles or through the use of self-adhesive pads. There are several electrode characteristics that can affect defibrillation outcome. These include electrode position, pad size and hand-held versus patch electrodes. About electrode position, data demonstrates that 4 pad positions (antero-lateral, antero-posterior, anterior-left infrascapular and anterior-right-infrascapular) are equally effective [47].For ease of placement and education, antero-lateral is a reasonable default electrode placement. Electrode pad size is an important determinant of transthoracic current flow during external shock. Larger paddles create a lower resistance and allow more current to reach the heart [48, 49] and may cause less myocardial necrosis [50]. Thus, larger paddles are more desirable. Most manufacturers offer adult paddles, which are between 8 to 13 cm in diameter, and pediatric paddles, which are smaller [51]. Hand-held paddle electrodes may be more effective than self-adhesive patch electrodes because if applied with pressure they may improve electrode-to-skin contact and reduce TTI [52]. Nevertheless they are never used for AEDs because of the need for training. One of the most important features of an ideal AED is the accuracy of rhythm diagnosis. As demonstrated in both in vitro and clinical studies, accuracy in terms of sensitivity and specificity is high, surpassing 90% [53, 54]. The rare errors noted in trials occurred when the device failed to recognize certain varieties of VF or when operators failed to follow recommended instructions [54, 55]. In order to diagnose VF the device must identify an ECG waveform with amplitude of at least 0.8mV faster than a preprogrammed rate while for VT the criteria are: frequency of at least 120 beats/minute, QRS duration of more than 160 ms and absence of P wave. ECG analysis is done in consecutive segments of 2.7 seconds and the diagnosis must coincide in 2 out of 3 segments in order to give a decision. Although AEDs are not designed to deliver synchronized shocks (such as cardioversion for VT with pulse), these devices will recommend a nonsynchronized shock for monomorphic or polymorphic VT if the rate and R-wave morphology exceed preset values. This is why AEDs should be placed in the analysis mode only when full cardiac arrest has been confirmed (patient unconscious) and all movement has ceased. There is evidence that VF waveform analysis can predict defibrillation success rate. Several animal and model studies suggest that this analysis may help to identify the optimal timing or waveform for each patient [56, 57]. However this feature is not yet sufficiently accurate to be implemented in clinical practice. Appropriate maintenance of the AED is vital for proper operation. AED manufacturers provide specific recommendations for maintenance and readiness, which should be followed carefully. Failure to properly maintain the defibrillator or power supply is responsible for the majority of reported malfunctions. Newer AED models require almost no maintenance. These devices conduct a self-check of operation and indicate “readiness to use”. AEDs are designed to be used by laypersons who ideally should have received AED training at some point in the past. Generally these devices are very intuitive and user-friendly so that even untrained bystanders can perfectly employ them to deliver an electric shock to a VF victim [58]. The basic steps common to all trademarks that need to be taken to deliver a shock are indicated in figure 4. In contrast, the more sophisticated manual and semi-automatic defibrillators used by health professionals can perform other functions but require a skilled operator able to interpret electrocardiograms. How to use an AED. Basic steps. The location of a public access AED should be displayed to large groups of people, regardless of age or activity. In order to make them highly visible, public access AEDs are often brightly colored, and are mounted in protective cases near the entrance of a building. In September 2008, the International Liaison Committee on Resuscitation issued a 'universal AED sign' to be adopted throughout the world to indicate the presence of an AED (figure 5). Universal AED sign When arriving at the scene of a suspected cardiac arrest, rescuers must rapidly integrate cardiopulmonary resuscitation (CPR) with the use of the available AED. In general 3 actions must occur simultaneously: (1) activation of the Emergency System, (2) CPR and (3) operation of the AED (figure 6). Latest European Resuscitation Council Guidelines [59] emphasize a number of changes compared to the 2005 version:
Modified prototype AEDs record information about frequency and depth of chest compressions during CPR. These devices are now commercially available and can prompt rescuers to improve CPR performance. AED and CPR algorithm. Cardiac arrest is less common in children than adults. In pediatric population cardiac arrest causes are more diverse with only 5% to 15% of all cases being attributed to VF [60]. The lowest-energy dose for effective defibrillation and upper limit for safe defibrillation in infants and children are not known, but doses > 4 J/kg have effectively defibrillated children [61] and pediatric animal models [62]. Biphasic shocks appear to be at least as effective as monophasic shocks and less harmful, initial doses of 2 J/kg may be considered. Some AEDs are equipped with pediatric attenuator systems to reduce the delivered energy to a dose suitable for children [63]. It seems that most AEDs can accurately detect VF in children with a high degree of sensitivity and specificity, but more studies are needed. European and AHA guidelines recommend the using conventional, adults AEDs in children > 8 years old (approximately 25 kg body weight) with the same energy recommendation as in adult population. In children < 8 years it is reasonable to use a pediatric dose-attenuator system but if none is available the rescuer should use a standard AED. Infants should be treated with manual or dose-attenuating defibrillators although there are isolated cases of adult AED use in infants with good outcomes and without apparent myocardial damage [64]. The design of AEDs is centered on being easy to use even for the untrained lay rescuers. A variety of studies have demonstrated that it is feasible especially when the rescuers receive instructions via telephone from emergency dispatchers [65, 66]. However, in order to improve outcomes in out-of-hospital cardiac arrests, the ‘ideal’ rescuer should have minimal training on AED use and basic CPR. Multiple approaches for AED training and maintenance of learned skills have been employed (face-to-face, video or web-based training) with various degrees of success [67, 68]. This concept includes all those strategies or programs to implement early defibrillation in the community. It has emerged from the recognition that AEDs and training lay people to use it are promising methods to achieve rapid defibrillation and survival in out-of-hospital cardiac arrest. Resuscitation guidelines recommend early defibrillation (within 5 minutes of collapse) in order to increase survival from out-of-hospital cardiac arrest. The only way to achieve this goal is by generalizing of AEDs in the community. It is now accepted than an AED should be available for immediate use by trained laypersons wherever large numbers of people congregate [69, 70] such as airports, convention centers, sports stadiums and arenas, large industrial buildings, high-rise offices, large health fitness facilities. Furthermore AED should be provided also to the traditional emergency medical services (EMS), to non-medical emergency responders (police officers and firefighters), as well as placed in hospitals and in the private homes of high-risk individuals.
The wearable cardioverter-defibrillator (WCD) (LifeVest®, ZOLL) is an external device capable of automatic detection and defibrillation of VT and VF. Its main indication is in situations where implantable cardioverter-defibrillator (ICD) may be initially deferred or may become unnecessary if the arrhythmic substrate is temporary or if the risk of ICD implantation is too high. While the WCD can be worn for years, typically the device is used for several months as temporary protection against cardiac arrest. The main indications were a WCD may be used are as follows:
This device is composed of four non adhesive monitoring electrodes, three defibrillation electrodes incorporated into a chest strap assembly and positioned for apex-posterior defibrillation and a defibrillation unit carried on a waist belt. The monitoring electrodes must be placed circumferentially around the chest and held in place with an elastic belt. They provide 2 surface ECG leads. It is essential that the vest be properly fitted in order to have adequate skin contact and avoid noise and frequent alarms. See figure 7. LifeVest®, ZOLL: main components and how it should be worn. Arrhythmia detection by the WCD is programmed using rate criteria. When an arrhythmia is detected, the WCD emits audible and vibration alarms. The patients are trained to hold response buttons during these alarms in order to avoid a shock while awake. If an electric shock will be delivered a voice cautions the patient and bystanders to the impending shock. A patient’s response serves as a test of consciousness; if no response occurs, the device charges, extrudes gel from the defibrillation electrodes, and delivers up to five biphasic shocks at preprogrammed energy levels with a maximum output of 150 joules. The tachycardia detection rate is programmable for VF between 120 and 250 beats/minute and the VF shock delay can be programmed from 25 to 55 seconds. The VT detection rate is programmable between 120 bpm to the VF setting with a VT shock delay of 60 to 180 seconds. Additional shock delays (up to 30 seconds) may optionally be allowed during sleep. VT signals can allow synchronized shock delivery on the R wave, but if the R wave cannot be identified, unsynchronized shocks will be delivered. The shock energy is biphasic and can be programmed from 75 to 150 joules, with up to five shocks delivered per event. The WCD has also the capability to store data regarding arrhythmias or asystole, patient’s compliance with the device, noise and interference. All this information is stored and later transmitted via modem to the manufacturer network where it is available for clinician review. Of note is that WCD cannot deliver either antitachycardia pacing or pacing for bradycardia or asystole. (cannot + either/or vs. can + neither/nor) In the USA postmarket study of 3569 patients, there were 80 sustained VT/VF events that occurred and the success of the first shock in terminating VT/VF in the unconscious patients was 100% with a survival rate of 86%. Death after a successful first shock occurred because recurrent VT/VF, bystander preventing therapy in one case, electrocardiogram signal disruption from a fall, and to inhibition of detection due to the pacing stimulus artifact from a unipolar pacemaker (one case). This study also reported that long-term survival was similar in WCD patients compared to a cohort of ICD patients [90]. Nevertheless, WCD does not offer pacemaker functions and in this study 23 out of 3569 patients (0.6%) experienced asystole with an associated mortality of 74% Although the WCD is a very efficient device, cardiac arrest still can develop in some circumstances: patient does not wear the device, WCD is improperly positioned, or bystander interference. These results highlight the importance of patient education and compliance while using the WCD. Some of the shocks that a WCD delivers may be inappropriate due to electronic noise, malfunction of the device or supraventricular tachycardia. The rate of inappropriate shocks by a WCD is comparable to the ICD rate [90, 91]. However WCD inappropriate shocks can be potentially reduced due to the ability to abort shock by pressing response buttons if the patient is awake. Also, when ECG noise occurs, the device emits an alarm prompting the patient to try to eliminate the electronic noise by changing body position or tightening of the electrode belt. In spite of being an extremely efficient device, WCD has some important limitations that need to be acknowledged. It does not provide pacemaker functions and it requires patient interaction and compliance. The device must be removed for bathing and during this time periods a caregiver should be present. In one German study [91], mean daily use of WCD was 21.3 hours/day. The primary complaints associated with the WCD were the weight of the device, problems sleeping, particularly when noise alarms occurred and skin rash or itching. In the past use of AEDs was limited partly because of the concern for subsidiary responsibility of those who are not health personnel. The fact that defibrillation is a medical act represents a legal obstacle in many countries. In 2000 the U.S. Congress approved the Act of survival in cardiac arrest, which extended the protection of the Good Samaritan to the users of an AED. Lay rescuers are protected from lawsuits if they act voluntarily to try to help a person who is having a medical emergency. The rescuer should act with good faith and make an effort help another person The rescuer’s efforts must be reasonable and with common sense. This has been an important step in the diffusion and generalization of these devices. While these devices are very effective when treating ventricular arrhythmias, they still the need the presence of a bystander capable of applying and operating it. Also, it must be taken into account, that only a half of the cardiac arrests are witnessed so for a large number of patients this therapy cannot be available. The main drawback that was observed when using an AED is that it requires interruptions in CPR in order to analyze the rhythm and to deliver the electric shock.Ongoing efforts are aimed at minimizing this time, and technical advances may eventually enable accurate rhythm interpretation even while CPR is ongoing [92, 93]. Recent resuscitation guidelines emphasize strongly the need to reduce ‘hands-off’ time in order to obtain a favorable result. It was advocated that AED should be included in the category of compulsory safety equipment such as smoke alarms or fire extinguishers. However this approach has not demonstrated survival benefit and at the moment is cost prohibitive. One of the future directions of research is AED analysis of shape and pattern of VF waveform recorded by ECG. It promises help in guiding the rescuers for the best course of treatment with CPR, defibrillation and medication. See section 3.3 Advertisement Sudden cardiac arrest, frequently due to VF or pulseless VT, is traditionally associated with poor survival rates. Saving the lives of these patients depends on early cardiac defibrillation which, with manual defibrillators, is limited only to qualified rescuers who can interpret ECGs. AEDs solve this problem since they are able to analyze rhythm and inform the rescuers whether a shock is indicated. This approach allows lay rescuers to provide effective early defibrillation which has been shown to significantly improve survival and survival with intact neurologic function after out-of-hospital cardiac arrest. One limitation is that AED use requires interruptions in CPR which was proved to be deleterious especially in patients with non-shockable rhythms. Special efforts are being made in order to improve rhythm analysis and ‘hands-off’ time during CPR.
Submitted: April 27th, 2012 Published: January 9th, 2013 © 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |